Oral presentation 3rd prize

Prize: Prize (including medals and awards)

Description

A phase I clinical trial on intratumoral administration of autologous CD1c(BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Degree of recognitionNational

Awarded at event

Event titleBACR Annual Meeting 2020
LocationVrije Universiteit Brussel, Campus Jette, Brussels, Belgium
Period7 Feb 2020 → 7 Feb 2020

    Fingerprint